Professor Terence Rabbitts

Biography

Terry is currently Professor of Molecular Biology at the University of Oxford. Terry worked in Cambridge from 1973-2006 in the MRC Laboratory of Molecular Biology where he was head of the Division of Protein & Nucleic Acid Chemistry until 2002. He moved to become Director of the Leeds Institute of Molecular Medicine (from 2006-2010). He is a Member of the European Molecular Biology Organization; a Fellow of the Royal Society; and a Founder Fellow of the Academy of Medical Sciences. His scientific work includes pioneering the method of cDNA cloning, mapping human antibody genes, methods for chimeric antibody production and single domains for blocking protein interactions inside cells. He defined the linkage of antibody and T cell receptor genes with cancer-specific chromosomal translocations, identified new families of oncogenes and identified a first gene fusion in a solid tumour. He developed the first gene fusion knock-in and also methods for creating chromosomal translocations de novo. Terry has considerable corporate biotechnology experience gained as chairman of the SAB of Cambridge Antibody Technology and Quadrant Healthcare until their respective IPOs; and as a member of the Domantis SAB until the company’s acquisition by GSK. He has also been a member of the SABs of Orison Genomics, DiThera and Kymab. He is currently a member of the SAB of Avacta and is a co-founder of Orbit Discovery Ltd.

Research Interest

protein